Fusion Pharmaceuticals Inc (NASDAQ:FUSN) Gets Upgrade
Fusion Pharmaceuticals Inc (NASDAQ:FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, stock rose 12.29% (As on December 27, 11:07:59 AM UTC-4, Source:…
